THERMOCOOL® SMARTTOUCH™ Catheter for the Treatment of Symptomatic Paroxysmal Atrial Fibrillation CONTINUED ACCESS

A phase 3 trial registered on ClinicalTrials.gov. The registry status is completed. It enrolled 148 participants.

Also called NCT01639495

  • Study
  • In this atlas

Overview

Design
Interventional study; allocation not applicable; no masking; primary purpose treatment
Phase
Phase 3
Enrolled
  • 148 participants (enrolled count) (from the registry)
Sponsor
Registry
  • NCT NCT01639495
Started
(actual) (from the registry)
Primary completion
(actual) (from the registry)
Completion
(actual) (from the registry)
Results first posted
(from the registry)
Countries
United States (from the registry)
Registry status
  • Completed (from the registry)

Technical summary

Registry record NCT01639495. Allocation not applicable; no masking; primary purpose treatment. Start 2012-07-01 (actual); primary completion 2014-06-01 (actual). Results posted on 2018-05-15.

The registry's words

Labels as the registry gives them, not rewritten.

Brief title
THERMOCOOL® SMARTTOUCH™ Catheter for the Treatment of Symptomatic Paroxysmal Atrial Fibrillation CONTINUED ACCESS
Condition
Drug Refractory Symptomatic Paroxysmal Atrial Fibrillation
Intervention (Device)
THERMOCOOL® SMARTTOUCH™ Catheter
Lead sponsor
Biosense Webster, Inc. (class: industry)

Record details

Record id
cardio:ct-nct01639495
Content hash
2d8b3e06c8ab9d07e61d92b857de4f936185b6d578bbe744a8f5505b88165442